Pembrolizumab in Relapsed or Refractory Mycosis Fungoides or Sézary Syndrome
JAMA Dermatology · 01.06.2025 · 161 (6) · 656
DOI: 10.1001/jamadermatol.2025.0251 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA Dermatology, erschienen am 01.06.2025. Verfasst von Omar Elghawy und 17 weiteren Autor:innen. Beteiligte Einrichtung: Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 6 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
This case series reported survival, response, and safety outcomes for patients with mycosis fungoides or Sézary syndrome who received pembrolizumab at a single institution.
Autor:innen und Institutionen
- Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia.
- Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia.
- Department of Radiation Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia.
Zitieren
APA
Elghawy, O., Sussman, J. H., Yang, A. G., Thomas, C. J., Carter, J. S., Landsburg, D. J., Svoboda, J., Kim, E., Rook, A. H., Chung, J., Plastaras, J. P., LaRiviere, M., Hubbeling, H., Chelius, M., Nasta, S. D., Chong, E. A., Schuster, S. J., & Barta, S. K. (2025). Pembrolizumab in Relapsed or Refractory Mycosis Fungoides or Sézary Syndrome. JAMA Dermatology, 161(6), 656. https://doi.org/10.1001/jamadermatol.2025.0251
Vancouver
Elghawy O, Sussman JH, Yang AG, Thomas CJ, Carter JS, Landsburg DJ, et al. Pembrolizumab in Relapsed or Refractory Mycosis Fungoides or Sézary Syndrome. JAMA Dermatology. 2025;161(6):656. doi:10.1001/jamadermatol.2025.0251
BibTeX
@article{Elghawy2025,
author = {Elghawy, Omar and Sussman, Jonathan H and Yang, Austin G and Thomas, Colin J and Carter, Jordan S and Landsburg, Daniel J and Svoboda, Jakub and Kim, Ellen and Rook, Alain H and Chung, Jina and Plastaras, John P and LaRiviere, Michael and Hubbeling, Harper and Chelius, Monica and Nasta, Sunita D and Chong, Elise A and Schuster, Stephen J and Barta, Stefan K},
title = {Pembrolizumab in Relapsed or Refractory Mycosis Fungoides or Sézary Syndrome},
journal = {JAMA Dermatology},
year = {2025},
volume = {161},
number = {6},
pages = {656},
doi = {10.1001/jamadermatol.2025.0251}
}
EUVIMED